Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?—Lessons Learned From Cancer

Overview of attention for article published in Frontiers in immunology, September 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 6 news outlets
twitter: 17 X users

patent: 1 patent

Citations

dimensions_citation: 36 Dimensions

Readers on

mendeley: 108 Mendeley

Summary News X Patents Dimensions citations

So far, Dimensions has found 36 publications that cite this research output.

36

The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.

Chapter 4 Cardiovascular medications and its relations with COVID-19 survival

Book chapter (January 2024)

Inborn errors of immunity: A field without frontiers

Article in Immunological Reviews (December 2023)

Celiprolol and sympatho‐immune interface in COVID‐19

Article in Immunology (September 2023)